Creo Medical Group plc entered into an agreement to sell a 51% stake in its European consumable business to Chinese medical device distributor, Micro-Tech Co. Ltd. for approximately €36.7 million (US$41 million) in cash on a cash free, debt free basis. Read More
The draft Medicare physician fee schedule for calendar year 2025 provoked a strong backlash from physician societies due to a net cut in physician pay. Device makers have their own concerns, including the latest in a series of controversies over coverage of skin substitutes. Read More
In what represents its first patenting, Roseville, Minn.-based Iveacare Inc. provides insights as to what its first therapeutic target will likely be since the developer of neuromodulation therapy devices emerged from stealth mode in April 2024 with the closing of $27.5 million series A financing. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alpha Tau, Bayer, Concentra Biosciences, Deephealth, Eli Lilly, Genincode, Koelis, Masimo, Nico, Pathpresenter, Personalaize, Radnet, Renovaro, Renovarocube, Singular Genomics Systems, Stryker, T2 Biosystems, Tandem Diabetes Care, Trinity Biotech, World Tumor Registry. Read More
